Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • After-Hours Center
  • Markets
  • Movers
  • Trading Ideas

26 Biotechnology Stocks Moving In Wednesday’s After-Market Session

By Benzinga Newsdesk
Today, 11:39 AM
Gainers • Innovate, Inc. (NASDAQ:INNT) stock rose 29.2% to $0.85 during Wednesday’s after-market session. • Genprex, Inc. (NASDAQ:GNPX)…

ACHV

Read More
3 minute read
  • After-Hours Center
  • Markets
  • Movers
  • Trading Ideas

36 Healthcare Stocks Moving In Wednesday’s After-Market Session

By Benzinga Newsdesk
Today, 11:39 AM
Gainers • Innovate, Inc. (NASDAQ:INNT) stock surged 29.2% to $0.85 during Wednesday’s after-market session. • Genprex, Inc. (NASDAQ:GNPX)…

ACHV

Read More
2 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News

Mid-Afternoon Market Update: FuelCell Energy Falls On Downbeat Q4 Results; Neurotrope Shares Rise

By Lisa Levin
Today, 11:39 AM
Toward the end of trading Wednesday, the Dow traded up 0.28% to 29,278.63 while the NASDAQ rose 0.57%…

ACMR

Read More
6 minute read
  • Intraday Update
  • Markets
  • Movers
  • Trading Ideas

98 Biotechnology Stocks Moving In Wednesday’s Session

By Benzinga Newsdesk
Today, 11:39 AM
Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock increased by 131.7% to $3.36 during Wednesday’s regular session. • Genprex, Inc.…

ACRS

Read More
7 minute read
  • Intraday Update
  • Markets
  • Movers
  • Trading Ideas

116 Healthcare Stocks Moving In Wednesday’s Session

By Benzinga Newsdesk
Today, 11:39 AM
Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock moved upwards by 133.1% to $3.38 during Wednesday’s regular session. • Genprex,…

ACRS

Read More
2 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News

Mid-Day Market Update: Crude Oil Down Over 2%; One Stop Systems Shares Surge

By Lisa Levin
Today, 11:39 AM
Midway through trading Wednesday, the Dow traded up 0.21% to 29257.26 while the NASDAQ rose 0.54% to 9,421.24.…

FCEL

Read More
3 minute read
  • Intraday Update
  • Markets
  • News
  • Trading Ideas

46 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin
Today, 11:39 AM
Gainers Neurotrope, Inc. (NASDAQ:NTRP) shares jumped 114.5% to $3.11 after the company announced it was awarded $2.7 million…

ACMR

Read More
1 minute read
  • Biotech
  • General
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Neurotrope Rips 150% Higher On Improved Alzheimer’s Data, NIH Funding

By Shanthi Rexaline
Today, 11:39 AM
Shares of thinly-traded microcap biopharma Neurotrope Inc (NASDAQ:NTRP) gap-opened sharply higher on above 50 times average volume following…

NTRP

Read More
3 minute read
  • Biotech
  • General

Neurotrope Awarded $2.7M In Funding By National Institute Of Health To Support Phase 2 Alzheimer’s Study

By Benzinga Newsdesk
Today, 11:39 AM
Analysis to adjust for significant baseline imbalance in Severe Impairment Battery scores between treatment groups shows improvement in…

NTRP

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service